SCHEMBL14655643

SCHEMBL14655643

O=C(O)c1c[nH]c2ncc(-c3cc(C(F)(F)F)ccn3)nc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 6/20 0.42
KMO O15229 2/20 0.41
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 2/20 0.40
KMT2A Q03164 2/20 0.40
HPGD P15428 1/20 0.40
ALOX12 P18054 1/20 0.40
SYK P43405 4/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C9 P11712 2/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
TTR P02766 1/20 0.37
CYP3A4 P08684 1/20 0.37
PKM P14618 1/20 0.37
NFKB1 P19838 1/20 0.37
UGT1A1 P22309 1/20 0.37
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14655380 0.88 JAK3 (0.41) SYKMAPK1CYP2C9JAK3
SCHEMBL14655756 0.82 PARP1 (0.51) MEN1ALDH1A1CYP1A2KMT2AHPGD
SCHEMBL14656000 0.82 SYK (0.46) KMOMEN1ALDH1A1CYP1A2KMT2A
SCHEMBL14655366 0.80 MAPK1 (0.47) SYKMAPK1CYP2C9DHODHJAK3
SCHEMBL14655425 0.79 CCR1 (0.47) ALDH1A1HPGDSYKMAPK1CYP2C9
SCHEMBL15755712 0.78 ALKBH5 (0.40) KMOMEN1ALDH1A1CYP1A2KMT2A
SCHEMBL14655475 0.78 KDM4C (0.43) SYKMAPK1CYP2C9JAK3
SCHEMBL14655368 0.78 AXL (0.47) CYP1A2SYKMAPK1CYP2C9LMNA
SCHEMBL14797132 0.78 SYK (0.37) SORT1MEN1ALDH1A1CYP1A2KMT2A
SCHEMBL14655604 0.77 MAPK1 (0.39) ALDH1A1HPGDSYKMAPK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518945-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-08-27 US claimed
EP-2550273-A2 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP claimed
CN-102803265-A Pyrrolopyrazine kinase inhibitors HOFFMANN LA ROCHE 2012-11-28 CN claimed
US-8518945-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-08-27 US disclosed
EP-2550273-A2 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP disclosed
CN-102803265-A Pyrrolopyrazine kinase inhibitors HOFFMANN LA ROCHE 2012-11-28 CN disclosed